United Therapeutics-UTHR November puts bid up on heavy volume for downside Hedge
UTHR, a biotechnology company involved in the development and commercialization of products for patients with chronic and life threatening diseases, is up .07 to $56.99. UTHR November 55 puts have traded 50 times on contract volume of 2,152 contracts, above its open interest 1,589 contracts according to Track Data. UTHR November 55 puts are bid $2.75, above its theoretical value of $2.04. Above average put option volume at price points above theoretical value indicates potential risks.